Following recent FDA approval of Biogen's Alzheimer antibody drug ADUHELM (TM), targeting oligomers of amyloid beta, Galimedix aims for first patients with its GAL-201 oral small molecule drug within one year.
Read Press ReleaseHEDscan is the world's first, commercially available, non-cryogenic, whole-head MEG system designed to expand the research and diagnosis of a broad range of mental health diseases
Read Press ReleaseEuropean neurostimulation devices market will register 16% CAGR up to 2025, driven by presence of prominent market players focusing on R&D of technologically driven products.
Read Press ReleaseAsia Pacific neurovascular devices market revenue exceeded USD 600 million in 2018 and is set to register healthy CAGR from 2019 to 2025, owing to rising awareness regarding advanced and innovative neurovascular devices.
Read Press ReleaseStudy aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients
Read Press ReleaseOssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced that it has established a US subsidiary and made initial key recruitments.
Read Press ReleaseFactors, such as a rising prevalence of neurological disorders, the growing popularity of minimally invasive neurosurgeries, the advent of new innovative neurointerventional devices, increasing market awareness & campaigns, and technological advancements are expected to drive the market growth during the forecast period.
Read Press ReleaseFactors such as rise in prevalence of neurosurgical disorders, increase in the adoption of minimally invasive neurosurgical procedures, the advent of new innovative neurosurgical devices, increasing market awareness & campaigns, and technological advancements are expected to drive the market growth during the forecast period.
Read Press Release